DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Welcure Drugs and Pharmaceuticals (BSE: WELCURE) Tracks Operations and Governance

Kalkine India 11 hrs ago·7 Sept 2026, 1:15 pm

Welcure Drugs & Pharmaceuticals

Welcure Drugs and Pharmaceuticals has initiated a comprehensive review of its operations and corporate governance. This internal audit is designed to assess the company's current management practices and ensure full compliance with regulatory standards. The move comes as part of the firm's commitment to transparency and maintaining robust oversight of its business activities.

For investors, this development signals a proactive approach to risk management. While the reasons for the review have not been disclosed, such measures are often taken to address internal processes or prepare for regulatory scrutiny. It is a positive step that reinforces the company's dedication to accountability and could help restore confidence among stakeholders.

Investors should watch for any official updates regarding the scope and timeline of this review. A clear communication strategy from the management will be crucial in mitigating uncertainty. Monitoring the company's future disclosures will provide better insight into the outcome of these governance checks.